US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AveXis

217.83

0.0000

Volume:- -

Turnover:- -

Market Cap:8.02B

PE:-17.55

High:217.83

Open:217.83

Low:217.83

Close:217.83

52wk High:217.94

52wk Low:65.54

Shares:36.82M

Float Shares:4.75M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-12.4093

EPS(LYR):-7.2841

ROE:--

ROA:--

PB:14.09

PE(LYR):-29.90

Loading ...

Overview Company News Filings

Company Profile

Company Name:

AveXis

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.avexis.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

AveXis, Inc., a clinical-stage gene therapy company, engages in developing and commercializing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases. Its initial product candidate is AVXS-101, a gene therapy product candidate that is in a Phase I clinical trial for the treatment of spinal muscular atrophy Type 1. The company also intends to identify, acquire, develop, and commercialize gene therapy product candidates for the treatment of other rare and life-threatening neurological genetic diseases. It has strategic collaboration and license agreements with Nationwide Children's Hospital; The Research Institute at Nationwide Children's Hospital; REGENXBIO Inc.; and Asklepios Biopharmaceutical, Inc. The company was formerly known as BioLife Cell Bank, Inc. and changed its name to AveXis, Inc. in January 2014. AveXis, Inc. was founded in 2010 and is headquartered in Bannockburn, Illinois.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AVXS/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVXS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVXS\",,,,,undefined,":{"symbol":"AVXS","market":"US","secType":"STK","nameCN":"AveXis","latestPrice":217.83,"timestamp":1543611600000,"preClose":217.83,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":4750000,"shares":36816476,"eps":-12.409272,"marketStatus":"Halted","change":0,"latestTime":"05-27 12:27:26 EDT","open":217.83,"high":217.83,"low":217.83,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-12.409272,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1779912000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1455166800000,"exchange":"NASDAQ","adjPreClose":217.83,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVXS\",,,,,undefined,":{"symbol":"AVXS","floatShares":4750000,"roa":"--","roe":"--","lyrEps":-7.284148,"shares":36816476,"dividePrice":0,"high":217.83,"amplitude":0,"preClose":217.83,"low":217.83,"week52Low":65.54,"pbRate":"14.09","week52High":217.94,"institutionHeld":0,"latestPrice":217.83,"eps":-12.409272,"divideRate":0,"volume":0,"delay":0,"ttmEps":-12.409272,"open":217.83,"prevYearClose":217.83},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVXS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-05-03","symbol":"AVXS","fiscalQuarterEnding":"2018/03","expectedEps":-1.95,"name":null,"time":"","type":"earning","dateTimestamp":1525320000000,"reportTimeType":"","actualEps":-6.2},{"market":"US","date":"2018-02-27","symbol":"AVXS","fiscalQuarterEnding":"2017/12","expectedEps":-1.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1519707600000,"reportTimeType":"post","actualEps":-2.55},{"market":"US","date":"2017-11-09","symbol":"AVXS","fiscalQuarterEnding":"2017/09","expectedEps":-1.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1510203600000,"reportTimeType":"post","actualEps":-1.52},{"market":"US","date":"2017-08-10","symbol":"AVXS","fiscalQuarterEnding":"2017/06","expectedEps":-0.97,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1502337600000,"reportTimeType":"post","actualEps":-2.07},{"market":"US","date":"2017-05-11","symbol":"AVXS","fiscalQuarterEnding":"2017/03","expectedEps":-0.88,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1494475200000,"reportTimeType":"post","actualEps":-1.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVXS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVXS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.avexis.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.0513},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.1043},{"period":"1year","weight":0.2961},{"period":"ytd","weight":0.1007}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"AveXis, Inc., a clinical-stage gene therapy company, engages in developing and commercializing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases. Its initial product candidate is AVXS-101, a gene therapy product candidate that is in a Phase I clinical trial for the treatment of spinal muscular atrophy Type 1. The company also intends to identify, acquire, develop, and commercialize gene therapy product candidates for the treatment of other rare and life-threatening neurological genetic diseases. It has strategic collaboration and license agreements with Nationwide Children's Hospital; The Research Institute at Nationwide Children's Hospital; REGENXBIO Inc.; and Asklepios Biopharmaceutical, Inc. The company was formerly known as BioLife Cell Bank, Inc. and changed its name to AveXis, Inc. in January 2014. AveXis, Inc. was founded in 2010 and is headquartered in Bannockburn, Illinois.","exchange":"NASDAQ","name":"AveXis","nameEN":"AveXis"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AVXS\",market:\"US\",,,undefined,":null}}